Clinical Trial Update: Respiratory Microbiota and Immune Response in CVID

View source ↗

Summary

The clinical trial NCT06173128 in common variable immunodeficiency has completed. It studied respiratory microbiota and immune responses in CVID patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Variable Immunodeficiency

Snippet

Sponsor: Boston University | Conditions: CVID | Status: COMPLETED